106 related articles for article (PubMed ID: 2318985)
1. Circulating high molecular weight IgG fibronectin complexes in myeloproliferative disorders.
Baglin TP; Price SM; Boughton BJ
J Clin Pathol; 1990 Feb; 43(2):102-5. PubMed ID: 2318985
[TBL] [Abstract][Full Text] [Related]
2. Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.
Baglin TP; Simpson AW; Price SM; Boughton BJ
J Clin Pathol; 1987 Dec; 40(12):1468-71. PubMed ID: 3429676
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating neutrophils with surface receptor activity for immunoglobulin G in polycythemia vera and myeloid metaplasia.
Gilbert HS; Goldberg R; Ward L
Blood; 1979 Jun; 53(6):1106-13. PubMed ID: 444652
[TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
Loni C; Ricci S; Azzarà A; Bertoncini G
Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
6. A reversible defect of platelet PDGF content in myeloproliferative disorders.
Baglin TP; Price SM; Boughton BJ
Br J Haematol; 1988 Aug; 69(4):483-6. PubMed ID: 3408684
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in myeloproliferative disorders.
Lewis CM; Pegrum GD
Lancet; 1977 Dec; 2(8049):1151-3. PubMed ID: 73061
[TBL] [Abstract][Full Text] [Related]
8. [An autopsy case of primary myelofibrosis with high value of circulating immune complexes, IgG(kappa) monoclonal gammopathy and extramedullary hematopoietic subcutaneous tumors].
Soga N; Sakai C; Shibata A; Honma K; Nemoto K
Rinsho Ketsueki; 1982 Nov; 23(11):1713-8. PubMed ID: 6820087
[No Abstract] [Full Text] [Related]
9. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.
Coppock JS; Scott DL; Carter SD; Moreland TM; Robinson MW
Rheumatol Int; 1986; 6(2):79-83. PubMed ID: 3764306
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis.
Baughn RE; McNeely MC; Jorizzo JL; Musher DM
J Immunol; 1986 Feb; 136(4):1406-14. PubMed ID: 2418114
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin levels in polycythemia vera, erythrocytosis, secondary polycythemia and myelofibrosis.
Meytes D; Shacked N; Padeh B; Czerniak P; Pinkhas J; Ramot B
Isr J Med Sci; 1972 Jul; 8(7):925-31. PubMed ID: 4115562
[No Abstract] [Full Text] [Related]
13. Immunologic dysfunction in the myeloproliferative disorders.
DiBella NJ; Brown GL
Cancer; 1978 Jul; 42(1):149-58. PubMed ID: 276412
[TBL] [Abstract][Full Text] [Related]
14. [The role of natural killer cell activity in the pathogenesis of chronic myeloproliferative diseases].
Guseva SA
Lik Sprava; 1993 Jul; (8):70-3. PubMed ID: 8079482
[TBL] [Abstract][Full Text] [Related]
15. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
Hasselbalch H; Clemmensen I
Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
[TBL] [Abstract][Full Text] [Related]
16. [Isolation and characteristics of immune complexes circulating in the serum of acute leukemia patients].
Dibrova TL; Kostrzhevskaia EG; Nizhinkovskaia TN; Korotkoruchko VP
Ukr Biokhim Zh (1978); 1984; 56(1):3-9. PubMed ID: 6710611
[TBL] [Abstract][Full Text] [Related]
17. Anti-IgG combined with rate nephelometry for measuring polyethylene glycol-precipitated circulating immune complexes.
Feldkamp CS; Levinson SS; Perry M; Amin V
Clin Chem; 1985 Dec; 31(12):2024-7. PubMed ID: 4064293
[TBL] [Abstract][Full Text] [Related]
18. Hypergammaglobulinemic purpura of Waldenström: characterization of circulating immune complexes.
Serino G; Pitingolo F; Granatieri C; Maresca V; Invernizzi F; Zara C; Zanussi C
Acta Haematol; 1983; 69(3):152-7. PubMed ID: 6404097
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
Ferraccioli G; Karsh J; Osterland CK
J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
[TBL] [Abstract][Full Text] [Related]
20. The polyethylene glycol precipitation technique and the particle-counting immunoassay for detection of circulating immune complex-like material in liver cirrhosis and septicemia.
Fink PC; Schultze KD
J Lab Clin Med; 1982 Jun; 99(6):852-65. PubMed ID: 7077126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
